U.S. market Closed. Opens in 37 minutes

IMTXW | immatics biotechnologies GmbH Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue54.00M172.83M34.76M31.25M18.45M3.77M
Cost of Revenue118.66M106.78M87.57M67.08M40.09M33.97M
Gross Profit-64.67M66.05M-52.81M-35.83M-21.64M-30.20M
Operating Expenses155.72M142.88M121.05M100.97M51.46M38.18M
Selling, General & Admin38.20M36.12M33.81M34.19M11.76M7.67M
Research & Development118.66M106.78M87.57M67.08M40.09M33.97M
Other Operating Expenses-1.14M-26.00K-332.00K-303.00K-385.00K-3.46M
Operating Income-101.72M29.95M-86.29M-69.72M-33.01M-34.41M
Other Expenses / Income4.73M12.08M-7.04M-142.13M526.00K2.05M
Before Tax Income-96.99M42.04M-93.33M-229.62M-32.49M-32.35M
Income Tax ExpensesN/A4.55M1.73M-268.00K-746.00K-2.96M
Net Income-96.99M37.51M-95.06M-229.35M-31.74M-31.44M
Interest Expenses831.00K8.28M1.73M289.00K170.00K16.00K
Basic Shares Outstanding80.55M67.22M62.91M48.00M62.91M62.91M
Diluted Shares Outstanding80.55M68.82M62.91M48.00M62.91M62.91M
EBITDA-88.93M50.04M-83.56M-64.44M-29.16M-31.73M
EBITDA Margin-164.69%28.95%-240.37%-206.19%-158.03%-841.54%
EBIT-96.16M50.34M-91.61M-229.33M-32.32M-34.39M
EBIT Margin-178.09%29.13%-263.52%-733.78%-175.17%-912.28%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙